In a healthcare market dominated by WebMD's $1B empire, a 3-person team is quietly stealing 1.4 million monthly visits by solving one brutal problem: finding the right specialist before your condition worsens. MediFind isn't just another doctor directory—it's a precision engine for time-starved patients.

"They're not competing on volume—they're winning on specificity. Every search query is a medical mystery, and MediFind is the detective."

The revenue model is equally intriguing: $0.2M annually from a 3-person team suggests either a subscription model for providers or affiliate partnerships. With no VC funding listed, this appears to be a bootstrapped operation that prioritizes sustainable growth over explosive scaling. The lack of social profiles and Trustpilot reviews is telling—they're not playing the typical B2C growth game. Instead, they're building a B2B2C infrastructure where the value is so clear that patients find them through medical communities and provider referrals.

• Precision over breadth: They own obscure medical conditions that bigger players ignore
• Zero paid traffic dependency: 74% organic is a founder's dream (and VC's nightmare)
• Structural advantage: Their physician structured data creates a moat that's hard to replicate
• The 3-person constraint is their superpower: no meetings, no politics, just shipping